Physician profile
Matthew C Bartram
NPI 1548669641
$6,610.31
in general payments reported to CMS, 2019-2025
8 companies · $942 in 2025
The $942 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $684 · 2022: $401 · 2023: $2,237 · 2024: $2,346 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,358 · Travel and Lodging: $2,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,358.15 |
| Travel and Lodging | $2,166.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,657.47 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Medtronic, INC. | $1,457.65 | 2023-2024 | Simulus, Avalus, Hancock II |
| Abbott Laboratories | $820.76 | 2023-2025 | Epic, Navitor, Thoratec Heartmate 3 Lvas Implant Kit |
| Zimmer Biomet Holdings, INC. | $380.72 | 2021-2024 | Ribfix Blu Advantage |
| Getinge USA Sales, LLC | $96.93 | 2021-2025 | Vasoview Hemopro 2 |
| Angiodynamics, INC. | $94.50 | 2022 | |
| Edwards Lifesciences Corporation | $72.65 | 2023-2024 | Mitris Resilia Mitral Valve |
| Terumo Medical Corporation | $29.63 | 2023 | Glidesheath Slender |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bartram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.